Valley National Advisers’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-776
| Closed | -$90K | – | 1293 |
|
2023
Q3 | $90K | Hold |
776
| – | – | 0.02% | 310 |
|
2023
Q2 | $80K | Hold |
776
| – | – | 0.01% | 331 |
|
2023
Q1 | $86K | Hold |
776
| – | – | 0.02% | 318 |
|
2022
Q4 | $87K | Buy |
776
+223
| +40% | +$25K | 0.02% | 320 |
|
2022
Q3 | $35K | Sell |
553
-248
| -31% | -$15.7K | 0.01% | 422 |
|
2022
Q2 | $67K | Hold |
801
| – | – | 0.01% | 314 |
|
2022
Q1 | $84K | Buy |
801
+140
| +21% | +$14.7K | 0.02% | 301 |
|
2021
Q4 | $71K | Hold |
661
| – | – | 0.01% | 321 |
|
2021
Q3 | $72K | Buy |
661
+303
| +85% | +$33K | 0.01% | 311 |
|
2021
Q2 | $34K | Hold |
358
| – | – | 0.01% | 401 |
|
2021
Q1 | $33K | Buy |
358
+63
| +21% | +$5.81K | 0.01% | 379 |
|
2020
Q4 | $22K | Hold |
295
| – | – | ﹤0.01% | 419 |
|
2020
Q3 | $23K | Buy |
+295
| New | +$23K | 0.01% | 386 |
|